THG
The Hanover Insurance Group, Inc.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
223.16
▲ 0.05 (0.02%)
MARKET · —
Price
Open
223.11
Prev close
223.11
Day high
224.82
Day low
222.69
Volume
206.84K
Market cap
$7.77B
P/E (TTM)
10.68
52W range
166.54 – 236.07
Trailing performance
Returnvs SPY
1W
-0.95%
+0.4%
1M
+4.22%
+0.5%
3M
+14.10%
+11.0%
6M
+26.85%
+15.8%
YTD
+22.10%
+9.8%
1Y
+28.36%
+8.4%
3Y
+105.19%
+31.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$7.77B
Enterprise value$8.35B
Revenue (TTM)$6.76B
Gross profit$1.70B
EBITDA—
Net income$753.80M
EPS (TTM)$20.89
Free cash flow$1.08B
Total cash$266.10M
Total debt$844.00M
Book value / share$105.23
Shares outstanding34.82M
Float34.46M
Short % of float2.48%
Dividend yield1.70%
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E10.68
Forward P/E11.43
PEG ratio0.34
Price / sales—
Price / book2.12
EV / revenue1.23
EV / EBITDA—
Gross margin25.19%
Operating margin14.75%
Profit margin11.17%
Return on equity21.88%
Return on assets3.89%
Debt / equity22.98
Current ratio0.36
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $6.32B | $6.08B | $5.81B | $5.48B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $662.50M | $426.00M | $35.30M | $116.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $662.50M | $426.00M | $35.30M | $116.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.76 | 5.31 | +41.3% |
| Mar 2026 | 4.22 | 5.25 | +24.5% |
| Dec 2025 | 5.03 | 5.79 | +15.1% |
| Sep 2025 | 4.22 | 5.09 | +20.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.46 | 7 | $1.79B | +3.1% |
| Next quarter | 5.48 | 7 | $1.63B | +9.6% |
| Current year | 20.38 | 8 | $6.77B | +7.1% |
| Next year | 19.53 | 8 | $7.06B | +4.3% |
Analyst targets & ownership
Mean target$236.50
High target$260.00
Low target$222.00
Implied upside5.98%
Analyst count8
ConsensusHOLD
Strong buy / Buy1 / 1
Hold6
Sell / Strong sell0 / 0
Held by insiders0.95%
Held by institutions92.97%
Institutions holding689
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+169.64K
Net buying
Buy transactions
49
219.95K shares
Sell transactions
12
50.30K shares
Net transactions
+61
Buys less sells
Sell : buy shares
0.2 : 1
Mixed
Insider-held shares
331.49K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | BUNTING THEODORE H JR Director |
SELL | 1.20K | $274.94K | Direct |
| Aug 3, 26 | CARLIN JANE D Director |
SELL | 1.00K | $231.50K | Direct |
| Jul 29, 26 | FARBER JEFFREY M Officer |
CONVERSION | 66.30K | $7.77M | Direct |
| Jun 26, 26 | KERRIGAN DENNIS FRANCIS Officer |
STOCK | 15 | $0 | Direct |
| Jun 26, 26 | LEE WILLARD T Officer |
STOCK | 10 | $0 | Direct |
| Jun 26, 26 | CONDRIN J PAUL Director |
STOCK | 3 | $0 | Direct |
| Jun 26, 26 | WARD ELIZABETH A Director |
STOCK | 3 | $0 | Direct |
| Jun 26, 26 | LOVELY DAVID JOHN Officer |
STOCK | 10 | $0 | Direct |
| Jun 26, 26 | DONNELL WILLIAM E Director |
STOCK | 3 | $0 | Direct |
| Jun 26, 26 | NORTON-GATTO PATRICIA A Officer |
STOCK | 5 | $0 | Direct |
| Jun 26, 26 | SALVATORE BRYAN J Officer |
STOCK | 24 | $0 | Direct |
| Jun 26, 26 | BRADICICH KEVIN J Director |
STOCK | 3 | $0 | Direct |
| Jun 26, 26 | LAVEY RICHARD W. Officer |
STOCK | 28 | $0 | Direct |
| Jun 26, 26 | ROCHE JOHN C. Chief Executive Officer |
STOCK | 122 | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRADICICH KEVIN J |
Director | 10.10K | Stock Award(Grant) |
CONDRIN J PAUL |
Director | 6.36K | Stock Award(Grant) |
EGAN CYNTHIA L |
Director | 10.21K | Stock Award(Grant) |
FARBER JEFFREY M |
Officer | 68.78K | Conversion of Exercise of derivative security |
KERRIGAN DENNIS FRANCIS |
Officer | 12.00K | Stock Award(Grant) |
LAVEY RICHARD W. |
Officer | 34.45K | Stock Award(Grant) |
LEE WILLARD T |
Officer | 5.99K | Stock Award(Grant) |
RAMRATH JOSEPH R |
Director | 33.83K | Stock Award(Grant) |
ROCHE JOHN C. |
Chief Executive Officer | 141.13K | Stock Award(Grant) |
SALVATORE BRYAN J |
Officer | 29.09K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
222.78
+0.17% from price
SMA 20
225.83
-1.18% from price
SMA 50
216.48
+3.09% from price
SMA 100
200.80
+11.14% from price
SMA 200
189.04
+18.05% from price
EMA 12
223.29
-0.06% from price
EMA 26
221.68
+0.67% from price
EMA 50
215.75
+3.43% from price
RSI (14)
52.7
Neutral
MACD (12,26,9)
1.62
Hist -1.25
ATR (14)
4.29
1.92% of price
Realised vol 30D
23.9%
Annualised
Bollinger upper
234.49
20, 2σ
Bollinger lower
217.17
20, 2σ
50 / 200 cross
Golden
216.48 vs 189.04
Trend bias
Above 200
+18.05%
Risk profile
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.07
Largely independent
Realised vol 30D
23.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-10.0%
Peak to trough
Max drawdown 5Y
-32.4%
Peak to trough
ATR 14
4.29
1.92% of price
Beta (reported)
0.28
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.01
Positioning, not flow
Max pain
220.00
-1.4% from spot
ATM implied vol
29.9%
Nearest strike to spot
Skew (10% OTM)
-14.5%
Calls bid over puts
Call volume
3
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
230.00
50 contracts
Heaviest put OI
220.00
1 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Hanover Insurance Group (THG) Stock Looks Fairly Valued Despite AM Best Rating Affirmation
Simply Wall St. · 2h ago
How Investors Are Reacting To Hanover Insurance Group (THG) Analyst Value Rating and CEO Succession Plan
Simply Wall St. · 4h ago
Hanover Insurance Group (THG) On Its Zacks Upgrade And The Undervalued Narrative
Simply Wall St. · 17h ago
Are Investors Undervaluing The Hanover Insurance Group (THG) Right Now?
Zacks · 1d ago
American Financial's Robust Financial Strength Fuels Dividend Growth
Zacks · 1d ago
Hanover Insurance Group Insider Sold Shares Worth $1,914,366, According to a Recent SEC Filing
MT Newswires · 1d ago
Zacks.com featured highlights Envista , Reliance, The Ensign, The Hanover Insurance and Lenovo
Zacks · 1d ago
4 Stocks Trading Near 52-Week High With More Upside Potential
Zacks · 2d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.